Pharmaceutical Business Intelligence

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

BUTABARB Drug Profile

« Back to Dashboard

Which patents cover Butabarb, and what substitute generic drugs are available?

Butabarb is a drug marketed by Alpharma Us Pharms, Bundy, Solvay, Whiteworth Town Plsn, Teva, Sandoz, Watson Labs, and Wockhardt. and is included in seventeen NDAs.

The generic ingredient in BUTABARB is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.

Summary for Tradename: BUTABARB

Bulk Api Vendors: see list18
Patent Applications: see list1,411
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BUTABARB at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms
butabarbital sodium
ELIXIR;ORAL085873-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
butabarbital sodium
TABLET;ORAL085934-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Whiteworth Town Plsn
butabarbital sodium
TABLET;ORAL083325-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Watson Labs
butabarbital sodium
TABLET;ORAL085772-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Whiteworth Town Plsn
butabarbital sodium
TABLET;ORAL083337-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.